You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 5, May 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (42)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dry Eye Syndromes
 •Articles for Residents
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Amniotic Membrane Inlay and Overlay Grafting for Corneal Epithelial Defects and Stromal Ulcers

Erik Letko, MD; Stephen U. Stechschulte, MD; Kenneth R. Kenyon, MD; Nadia Sadeq, MD; Tatiana R. Romero, MD; C. Michael Samson, MD; Quan D. Nguyen, MD; Stephanie L. Harper, MD; Jonathan D. Primack, MD; Dimitri T. Azar, MD; Martin Gruterich, MD; Claes H. Dohlman, MD; Stefanos Baltatzis, MD; C. Stephen Foster, MD

Arch Ophthalmol. 2001;119:659-663.

Objectives  To determine the effect of amniotic membrane transplantation (AMT) on persistent corneal epithelial defects (PEDs) and to compare the efficacy between inlay and overlay techniques.

Methods  Thirty patients (30 eyes) underwent AMT for PED. The use of AMT was restricted to patients in whom all previous measures, including bandage contact lens and tarsorrhaphy, had failed. The amniotic membrane was placed on the surface of the cornea in overlay (group A) or inlay (group B) fashion.

Results  The PED healed after the first AMT in 21 eyes (70%) within an average of 25.5 days after surgery and recurred in 6 eyes (29%). Among the 22 eyes treated with an overlay AMT (group A), the PED healed after the first AMT in 14 eyes (64%) within an average of 24.5 days and recurred in 4 eyes (29%). Among the 8 eyes treated with an inlay AMT (group B), the PED healed within an average of 27.4 days after AMT, which did not statistically significantly differ from group A (P = .72). The PED healed after the first AMT in 7 eyes (88%) and recurred in 2 (29%) of 7 eyes.

Conclusions  The AMT can be helpful in the treatment of PED in which all other conventional management has failed. However, the success rate in our study was not as high as that previously reported, and our results showed a high incidence of recurrences of epithelial defects. We did not find any difference between overlay and inlay techniques in terms of healing time and recurrence rate.


From the Immunology and Uveitis Service (Drs Letko, Romero, Samson, Nguyen, Harper, and Foster) and Cornea Service (Drs Stechschulte, Primack, Azar, and Dohlman), Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston; Cornea Consultants, Boston (Drs Stechschulte and Kenyon); Ludwigs Maximilian Universitat Augenklinik, München, Germany (Drs Kenyon and Gruterich); Al-Bahar Ophthalmology Center, IBN Sina Hospital, Safat, Kuwait (Dr Sadeq); and General Hospital of Athens, University Eye Clinic, Athens Medical School, Athens, Greece (Dr Baltatzis).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Amniotic membrane transplantation for the management of corneal epithelial defects: an in vivo confocal microscopic study
Nubile et al.
Br J Ophthalmol 2008;92:54-60.
ABSTRACT | FULL TEXT  

Amniotic membrane transplantation for ocular disease: a review of the first 233 cases from the UK user group
Saw et al.
Br J Ophthalmol 2007;91:1042-1047.
ABSTRACT | FULL TEXT  

Histopathology and Ultrastructure of Human Corneas After Amniotic Membrane Transplantation
Seitz et al.
Arch Ophthalmol 2006;124:1487-1490.
FULL TEXT  

Adhesion Structures of Amniotic Membranes Integrated into Human Corneas
Resch et al.
IOVS 2006;47:1853-1861.
ABSTRACT | FULL TEXT  

Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber.
Wang et al.
IOVS 2006;47:1522-1532.
ABSTRACT | FULL TEXT  

Induced Expression of Insulin-like Growth Factor-1 by Amniotic Membrane-Conditioned Medium in Cultured Human Corneal Epithelial Cells.
Lee et al.
IOVS 2006;47:864-872.
ABSTRACT | FULL TEXT  

Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation
Heiligenhaus et al.
Br J Ophthalmol 2003;87:1215-1219.
ABSTRACT | FULL TEXT  

The Role of NGF Signaling in Human Limbal Epithelium Expanded by Amniotic Membrane Culture
Touhami et al.
IOVS 2002;43:987-994.
ABSTRACT | FULL TEXT  

Amniotic membrane transplantation for persistent corneal epithelial defect
TSENG
Br J Ophthalmol 2001;85:1400-1401.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.